Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases

WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases
Conditions:   Anaplastic Astrocytoma, IDH-Wildtype;   Glioblastoma, IDH-Wildtype;   Lung Non-Small Cell Carcinoma;   Metastatic Malignant Neoplasm in the Central Nervous System;   Metastatic Malignant Neoplasm in the Leptomeninges
Interventions:   Drug: EGFR/EGFRvIII Inhibitor WSD0922-FU;   Procedure: Therapeutic Conventional Surgery
Sponsors:   Mayo Clinic;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 24, 2019 / by / in
Comments